NCT06369662
CD155 Expression in Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT06643962
Venetoclax Combined With Intensive Therapy for Acute Myeloid Leukemia Patients With Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy No drug interventions treatment Not Available not_yet_recruiting NCT05282459
Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation supportive_care 1 / 2 active_not_recruiting NCT06537726
Breath Analysis for the Detection of Invasive Fungal Infections No drug interventions Not Available Not Available recruiting NCT00339664
Analyses of Human Samples Collected in Clinical Trials No drug interventions Not Available Not Available completed NCT02916979
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG treatment 1 completed NCT00611247
Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia treatment 2 completed NCT05805605
Allo HSCT Using RIC and PTCy for Hematological Diseases treatment 2 recruiting NCT00451997
Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes treatment 2 completed NCT00512083
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia treatment 2 completed NCT02370888
Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease treatment 1 terminated NCT04406207
Endogenous Retroviruses in Acute Myeloid Leukemia No drug interventions Not Available Not Available withdrawn NCT06152809
CIML NK Cells With Venetoclax for AML treatment 1 active_not_recruiting NCT04039100
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease No drug interventions supportive_care Not Available completed NCT01050036
Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia No drug interventions treatment Not Available unknown_status NCT05458258
Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia No drug interventions Not Available Not Available recruiting NCT04748848
A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy treatment 1 terminated NCT02538965
A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia treatment 2 completed NCT00025662
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS No drug interventions treatment 2 completed NCT04598789
A Multicentre, Retrospective Study to Evaluate the Outcome of HSCT Mismatch Unrelated Donors No drug interventions Not Available Not Available completed NCT01392989
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders treatment 2 completed NCT04310592
Natural Killer Cell (CYNK-001) Infusions in Adults With AML treatment 1 recruiting NCT02333838
Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies other 2 unknown_status NCT00065143
Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome treatment 2 completed NCT06138587
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation treatment 1 recruiting NCT00568633
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML treatment 3 terminated NCT01144793
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias No drug interventions Not Available Not Available completed NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia treatment 1 recruiting NCT00233909
A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia treatment 1 / 2 completed NCT00306332
T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation No drug interventions treatment 3 terminated NCT01602952
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI treatment 1 / 2 completed NCT02577406
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation treatment 3 completed NCT06501196
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome No drug interventions treatment 1 recruiting NCT03600558
Efficacy of FLAG Regimen for the Treatment of Patients With AML No drug interventions Not Available Not Available unknown_status NCT04265963
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 / 2 recruiting NCT00030186
Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation treatment 2 completed NCT03080922
High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML No drug interventions treatment 1 / 2 unknown_status NCT04272125
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 / 2 recruiting NCT03066648
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS treatment 1 completed NCT03417427
A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML treatment 2 recruiting NCT01511289
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients treatment 3 completed NCT05143840
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase treatment 2 recruiting NCT00129168
Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) treatment 1 / 2 completed NCT06512610
ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML No drug interventions Not Available Not Available not_yet_recruiting NCT04789655
Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT05194397
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors No drug interventions treatment 2 recruiting NCT01643603
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies treatment 1 terminated NCT00422890
Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®) No drug interventions treatment 3 completed NCT03659084
Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation Not Available Not Available unknown_status NCT06130579
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT No drug interventions treatment 2 recruiting NCT05031897
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant treatment 2 recruiting NCT00126893
Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia treatment 1 terminated NCT05363488
Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland Not Available Not Available completed NCT02763475
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents treatment 2 completed NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies No drug interventions treatment 1 / 2 unknown_status NCT05309018
Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML No drug interventions Not Available Not Available withdrawn NCT04260022
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL treatment 1 recruiting NCT00001748
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies No drug interventions treatment 1 completed NCT00887926
Study of IMC-EB10 in Participant With Leukemia No drug interventions treatment 1 terminated NCT06235801
A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia treatment 1 / 2 recruiting NCT00967343
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor No drug interventions prevention 2 / 3 terminated NCT00521664
A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups No drug interventions treatment 3 completed NCT00114764
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) treatment 2 completed NCT02719821
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT05787951
Frequency and Risk Factors of Acute Myeloid Leukemia No drug interventions Not Available Not Available not_yet_recruiting NCT00111345
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents treatment 2 / 3 unknown_status NCT01380756
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT00001637
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults No drug interventions treatment 2 completed NCT05035706
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors No drug interventions treatment 0 recruiting NCT06429449
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia treatment 1 recruiting NCT01066286
Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia No drug interventions Not Available Not Available unknown_status NCT01779882
Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT treatment Not Available completed NCT03613727
Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients treatment 2 completed NCT00497991
Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia treatment 1 completed NCT02489929
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine diagnostic Not Available unknown_status NCT00543972
Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia treatment 1 terminated NCT04714372
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia treatment 1 active_not_recruiting NCT01760655
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies treatment 2 completed NCT05871008
Integrated Actionable Aging Assessment for Cancer Patients Pilot No drug interventions health_services_research Not Available recruiting NCT04628338
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation treatment 0 completed NCT01066338
Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype No drug interventions Not Available Not Available unknown_status NCT02955043
Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery No drug interventions supportive_care Not Available completed NCT00780104
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias treatment 1 completed